Advertisement

International Ophthalmology

, Volume 39, Issue 2, pp 477–484 | Cite as

Intravitreal aflibercept for the treatment of choroidal neovascularization associated with rubella retinopathy

  • Hasan KiziltoprakEmail author
  • Esat Yetkin
  • Kemal Tekin
  • Mustafa Koc
  • İrfan Akalin
  • Mehmet Yasin Teke
Case Report

Abstract

Purpose

To report a case of choroidal neovascularization (CNV) associated with rubella retinopathy (RR) treated with intravitreal aflibercept.

Case presentation

A 15-year-old girl presented a complaint of visual decrease in her left eye. She had a history of hearing decrease since she was 1 year old in addition to patent ductus arteriosus. On ocular examination, the best corrected visual acuity (BCVA) was 20/20 in the right eye and 20/400 in the left eye. Dilated fundus examinations revealed a classic salt-and-pepper appearance in both eyes and a whitish subretinal lesion with retinal hemorrhages in the left macula. Fundus fluorescein angiography (FFA) of the left eye illustrated a pattern of diffuse spotty fluorescence with an active subfoveal CNV lesion, that hyperfluoresces in the early phases of the FFA, maintains well-demarcated borders, and leaks. Spectral domain optical coherence tomography (SD-OCT) revealed thickened and elevated retinal layers at the macula due to the subretinal and intraretinal fluid with foveal and extrafoveal protruding hyper-reflective lesion in the left eye. Single dose of intravitreal aflibercept was performed to the left eye and at the first month after the injection, the BCVA improved to 20/100 and the OCT revealed scar formation. At the follow-up visits, the macula was similar to those at the first month post-injection, and the BCVA was preserved. No additional injections were needed.

Conclusion

Intravitreal aflibercept may be a treatment alternative, which provides satisfactory anatomical and functional results and leads to a better visual acuity in cases with RR complicated by CNV.

Keywords

Choroidal neovascularization Intravitreal aflibercept Rubella retinopathy 

Notes

Compliance with ethical standards

Conflicts of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this paper.

References

  1. 1.
    Bianco V, Spera AM, Simeone D, Tosone G, Orlando R (2017) An update on epidemiology of congenital rubella syndrome: How far from the World Health Organization goals? Minerva Med 108:483–485Google Scholar
  2. 2.
    Krill AE (1967) The retinal disease of rubella. Arch Ophthalmol 77:445–449CrossRefGoogle Scholar
  3. 3.
    Frank KE, Purnell EW (1978) Subretinal neovascularization following rubella retinopathy. Am J Ophthalmol 86:462–466CrossRefGoogle Scholar
  4. 4.
    Yoser SL, Forster DJ, Rao NA (1993) Systemic viral infections and their retinal and choroidal manifestations. Surv Ophthalmol 37:313–352CrossRefGoogle Scholar
  5. 5.
    Yazigi A, De Pecoulas AE, Vauloup-Fellous C, Grangeot-Keros L, Ayoubi JM, Picone O (2017) Fetal and neonatal abnormalities due to congenital rubella syndrome: a review of literature. J Matern Fetal Neonatal Med 30:274–278CrossRefGoogle Scholar
  6. 6.
    Lambert N, Strebel P, Orenstein W, Icenogle J, Poland GA (2015) Rubella. Lancet 385:2297–2307CrossRefGoogle Scholar
  7. 7.
    Tamayo ML, García N, Bermúdez Rey MC, Morales L, Flórez S, Varón C, Gelvez N (2013) The importance of fundus eye testing in rubella-induced deafness. Int J Pediatr Otorhinolaryngol 77:1536–1540CrossRefGoogle Scholar
  8. 8.
    Godberg N, Chou J, Moore A, Tsang S (2009) Autofluorescence imaging in rubella retinopathy. Ocul Immunol Inflamm 17:400–402CrossRefGoogle Scholar
  9. 9.
    Sickenberg M, Schmidt-Erfurth U, Miller JW, Pournaras CJ, Zografos L, Piguet B et al (2000) A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol 118:327–336CrossRefGoogle Scholar
  10. 10.
    Newman DK (2016) Photodynamic therapy: current role in the treatment of chorioretinal conditions. Eye (Lond) 30:202–210CrossRefGoogle Scholar
  11. 11.
    Wang LK, Kansal S, Pulido JS (2002) Photodynamic therapy for the treatment of choroidal neovascularization secondary to rubella retinopathy. Am J Ophthalmol 134:790–792CrossRefGoogle Scholar
  12. 12.
    Wormald R, Evans J, Smeeth L, Henshaw K (2007) Photodynamic therapy for neovascular age-related macular degeneration. Cochrane Database Syst Rev 18:CD002030Google Scholar
  13. 13.
    Battaglia Parodi M, Romano F, Montagna M, Bandello F (2017) Large choroidal excavation in a patient with rubella retinopathy. Eur J Ophthalmol.  https://doi.org/10.5301/ejo.5001056 Google Scholar
  14. 14.
    Stewart MW, Rosenfeld PF (2008) Predicted biological activity of intravitreal VEGF trap. Br J Ophthalmol 92:667–668CrossRefGoogle Scholar
  15. 15.
    Veloso CE, Costa RA, Orefice JL, Orefice F (2007) Spontaneous involution of choroidal neovascularizaiton secondary to rubella retinopathy. Eye (Lond) 21:1429–1430CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2018

Authors and Affiliations

  • Hasan Kiziltoprak
    • 1
    Email author
  • Esat Yetkin
    • 1
  • Kemal Tekin
    • 2
  • Mustafa Koc
    • 1
  • İrfan Akalin
    • 3
  • Mehmet Yasin Teke
    • 4
  1. 1.Ulucanlar Eye Training and Research HospitalAnkaraTurkey
  2. 2.Kars State HospitalKarsTurkey
  3. 3.Artvin State HospitalArtvinTurkey
  4. 4.Department of Retinal DiseasesUlucanlar Eye Training and Research HospitalAnkaraTurkey

Personalised recommendations